Combined antibacterial activity of phage lytic proteins holin and lysin from Streptococcus suis bacteriophage SMP

Yibo Shi1, Ning Li, Yaxian Yan

  • 1Department of Animal Science, School of Agriculture and Biology, Shanghai Jiao Tong University, Shanghai Key Laboratory of Veterinary Biotechnology, Shanghai, People's Republic of China.

Current Microbiology
|April 25, 2012
PubMed

Insights

Novel antibacterial agents are crucial for combating multidrug-resistant Streptococcus suis. Researchers explored holin (HolSMP) and lysin (LySMP) from a S. suis bacteriophage, finding their combined use a promising strategy against resistant bacteria.

Area of Science:

  • Microbiology
  • Bacteriology
  • Antimicrobial Research

Background:

  • Multidrug-resistant Streptococcus suis poses a significant threat to public health.
  • Novel antibacterial strategies are urgently needed to overcome antimicrobial resistance.
  • Bacteriophage-derived proteins, holins and lysins, show potential as antimicrobial agents.

Purpose of the Study:

  • To investigate the antibacterial activity of holin (HolSMP) and lysin (LySMP) from Streptococcus suis serotype 2 bacteriophage SMP.
  • To evaluate the potential of these proteins, individually and in combination, as novel antibacterial agents.
  • To explore their efficacy against multidrug-resistant bacterial strains.

Main Methods:

  • HolSMP and LySMP were expressed in Escherichia coli BL21(DE3).
  • Antibacterial activity was assessed at optimal conditions (37°C, pH 5.2, 0.8% β-mercaptoethanol).
  • Lytic spectra of purified HolSMP, LySMP, and their mixture were determined against various bacterial species.

Main Results:

  • Both HolSMP and LySMP demonstrated efficient lytic activity under tested conditions.
  • HolSMP showed activity against Staphylococcus aureus and Bacillus subtilis, which were resistant to LySMP.
  • The combination of HolSMP and LySMP broadened the lytic spectrum, enhancing overall antibacterial efficacy.

Conclusions:

  • HolSMP and LySMP are effective antibacterial agents derived from S. suis bacteriophage SMP.
  • HolSMP exhibits a distinct lytic spectrum and can enhance the activity of LySMP.
  • The combined use of holin and lysin presents a viable strategy for developing novel treatments against drug-resistant bacteria.

Related Concept Videos

Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
Lysogenic Cycle of Bacteriophages00:43

Lysogenic Cycle of Bacteriophages

In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...